Choose Your Consultation
Select an in-person, telemedicine, or neurological and autoimmune consultation according to your needs, location and availability.
Review the available formats, support periods, request process and important eligibility information before submitting an enquiry.
Three guided steps help the clinical team understand your needs and prepare an informed consultation.
Select an in-person, telemedicine, or neurological and autoimmune consultation according to your needs, location and availability.
Complete the consultation request with your contact information, consultation preference, diagnosis if known and a brief medical summary.
Following a comprehensive review, you will receive an organized assessment and personalized roadmap to discuss with your treating physician or oncology team.
Clear pricing, defined support periods and no hidden consultation fees.
One-time consultation fee
One-time consultation fee
USD · One-time consultation fee
Submitting a request does not confirm an appointment. Consultation availability may depend on clinical suitability, location and applicable jurisdictional requirements. This service is not for medical emergencies.
Yes. The consultation considers your diagnosis, medical history, current treatments and individual circumstances. Any recommendations should also be reviewed with your licensed treating clinician.
The initial support period is three months. Timing may be adjusted according to response, tolerability, clinical monitoring and guidance from your treating clinician.
Reassessment may include symptoms, appropriate blood markers and imaging such as CT, MRI or PET/CT when ordered by your treating clinician.
No responsible timeline can be guaranteed. Outcomes vary substantially by cancer type, stage, biology, treatment and individual response. Your oncology team is best placed to discuss prognosis.
Compatibility cannot be assumed. Some medicines and supplements can interact with chemotherapy, so every component must be reviewed with your oncologist or oncology pharmacist before and during treatment.
Compatibility depends on the specific medicines, diagnosis and treatment plan. Review every component with your oncology team before combining it with immunotherapy.
Some products may affect treatment response or side effects. Coordinate any proposed protocol with your radiation oncologist before and throughout radiation therapy.
Do not replace or delay evidence-based cancer treatment without speaking with a qualified oncology team. The risks and potential benefits depend on your individual clinical situation.
Only begin components after clinician or pharmacist review. Individual products can still cause side effects or interactions, and partial regimens may not be appropriate for your situation.
Stop the suspected product and contact your treating clinician promptly. Seek urgent or emergency care for severe symptoms, and do not restart it until a qualified clinician has reviewed the reaction.